Warburg Pincus China-Southeast Asia II (Cayman), L.P. - Net Worth and Insider Trading

Warburg Pincus China-Southeast Asia II (Cayman), L.P. Net Worth

The estimated net worth of Warburg Pincus China-Southeast Asia II (Cayman), L.P. is at least $162 Million dollars as of 2024-06-17. Warburg Pincus China-Southeast Asia II (Cayman), L.P. is the 2201 Interest of corporation controlled by you of Gaush Meditech Ltd and owns about 11,375,840 shares of Gaush Meditech Ltd (HKSE:02407) stock worth over $162 Million. Details can be seen in Warburg Pincus China-Southeast Asia II (Cayman), L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Warburg Pincus China-Southeast Asia II (Cayman), L.P. has not made any transactions after 2022-12-12 and currently still holds the listed stock(s).

Transaction Summary of Warburg Pincus China-Southeast Asia II (Cayman), L.P.

To

Warburg Pincus China-Southeast Asia II (Cayman), L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Warburg Pincus China-Southeast Asia II (Cayman), L.P. owns 1 companies in total, including Gaush Meditech Ltd (HKSE:02407) .

Click here to see the complete history of Warburg Pincus China-Southeast Asia II (Cayman), L.P.’s form 4 insider trades.

Insider Ownership Summary of Warburg Pincus China-Southeast Asia II (Cayman), L.P.

Ticker Comapny Transaction Date Type of Owner
HKSE:02407 Gaush Meditech Ltd 2022-12-12 2201 Interest of corporation controlled by you

Warburg Pincus China-Southeast Asia II (Cayman), L.P. Latest Holdings Summary

Warburg Pincus China-Southeast Asia II (Cayman), L.P. currently owns a total of 1 stock. Warburg Pincus China-Southeast Asia II (Cayman), L.P. owns 11,375,840 shares of Gaush Meditech Ltd (HKSE:02407) as of December 12, 2022, with a value of $162 Million.

Latest Holdings of Warburg Pincus China-Southeast Asia II (Cayman), L.P.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02407 Gaush Meditech Ltd 2022-12-12 11,375,840 14.20 161,536,928

Holding Weightings of Warburg Pincus China-Southeast Asia II (Cayman), L.P.


Warburg Pincus China-Southeast Asia II (Cayman), L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, Warburg Pincus China-Southeast Asia II (Cayman), L.P. has made a total of 1 transactions in Gaush Meditech Ltd (HKSE:02407) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Gaush Meditech Ltd is the sale of 11,375,840 shares on December 12, 2022, which brought Warburg Pincus China-Southeast Asia II (Cayman), L.P. around $0.

Insider Trading History of Warburg Pincus China-Southeast Asia II (Cayman), L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Warburg Pincus China-Southeast Asia II (Cayman), L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Warburg Pincus China-Southeast Asia II (Cayman), L.P. Ownership Network

Ownership Network List of Warburg Pincus China-Southeast Asia II (Cayman), L.P.

No Data

Ownership Network Relation of Warburg Pincus China-Southeast Asia II (Cayman), L.P.

Insider Network Chart

Warburg Pincus China-Southeast Asia II (Cayman), L.P. Owned Company Details

What does Gaush Meditech Ltd do?

Who are the key executives at Gaush Meditech Ltd?

Warburg Pincus China-Southeast Asia II (Cayman), L.P. is the 2201 Interest of corporation controlled by you of Gaush Meditech Ltd. Other key executives at Gaush Meditech Ltd include 2102 Investment manager OrbiMed Advisors III Limited , 2102 Investment manager OrbiMed Asia GP III, L.P. , and 2102 Investment manager OrbiMed Asia Partners III, L.P. .

Gaush Meditech Ltd (HKSE:02407) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Gaush Meditech Ltd (HKSE:02407) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Gaush Meditech Ltd (HKSE:02407) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Gaush Meditech Ltd (HKSE:02407)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Gaush Meditech Ltd Insider Transactions

No Available Data

Warburg Pincus China-Southeast Asia II (Cayman), L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for Warburg Pincus China-Southeast Asia II (Cayman), L.P.. Currently GuruFocus does not have mailing address information for Warburg Pincus China-Southeast Asia II (Cayman), L.P..

Discussions on Warburg Pincus China-Southeast Asia II (Cayman), L.P.

No discussions yet.